Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial-Reference-Cited by-同舟云学术

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

Published:2020-06 Issue:6 Volume:31 Page:789-797
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Schuler M.,Berardi R.,Lim W.-T.,de Jonge M.,Bauer T.M.,Azaro A.,Gottfried M.,Han J.-Y.,Lee D.H.,Wollner M.,Hong D.S.,Vogel A.,Delmonte A.,Akimov M.,Ghebremariam S.,Cui X.,Nwana N.,Giovannini M.,Kim T.M.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference32 articles.

1. Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients;Cappuzzo;J Clin Oncol,2009

2. Targeting MET amplification as a new oncogenic driver;Kawakami;Cancers (Basel),2014

3. MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lung;Schildhaus;Clin Cancer Res,2015

4. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib;Bean;Proc Natl Acad Sci U S A,2007

5. MET as a possible target for non-small-cell lung cancer;Sadiq;J Clin Oncol,2013

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Non-Small Cell Lung Cancer;Clinical Lung Cancer;2024-09

2. Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations;European Journal of Cancer;2024-08

3. Rediscovering immunohistochemistry in lung cancer;Critical Reviews in Oncology/Hematology;2024-08

4. Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance;npj Precision Oncology;2024-07-26

5. Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review;Cancers;2024-06-26